精神心理科指南

订阅

MedSci主页 / 所有栏目 / 精神心理科指南

NICE指南：儿童和青年抑郁症鉴别与治疗

2019-10-01 国家卫生和护理研究所（NICE） NICE

抑郁症

本指南涵盖了识别和管理5至18岁儿童和年轻人的抑郁症。 它基于分步护理模型，旨在提高对轻度，中度至重度抑郁症的认识和评估，并促进有效的治疗。

中文标题：

NICE指南：儿童和青年抑郁症鉴别与治疗

英文标题：

Depression in children and young people: identification and management

发布机构：

国家卫生和护理研究所（NICE）

发布日期：

2019-10-01

简要介绍：

本指南涵盖了识别和管理5至18岁儿童和年轻人的抑郁症。 它基于分步护理模型，旨在提高对轻度，中度至重度抑郁症的认识和评估，并促进有效的治疗。

相关资料下载：
[AttachmentFileName(sort=1, fileName=66.pdf)] GetToolGuiderByIdResponse(projectId=1, id=b07571c002058534, title=NICE指南：儿童和青年抑郁症鉴别与治疗, enTitle=Depression in children and young people: identification and management, guiderFrom=NICE, authorId=0, author=, summary=本指南涵盖了识别和管理5至18岁儿童和年轻人的抑郁症。 它基于分步护理模型，旨在提高对轻度，中度至重度抑郁症的认识和评估，并促进有效的治疗。, cover=, journalId=0, articlesId=null, associationId=1435, associationName=国家卫生和护理研究所（NICE）, associationIntro=, copyright=0, guiderPublishedTime=Tue Oct 01 00:00:00 CST 2019, originalUrl=, linkOutUrl=, content=<p><span class="VIiyi" lang="zh-CN"><span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="0">本指南涵盖了识别和管理5至18岁儿童和年轻人的抑郁症。</span> <span class="JLqJ4b ChMk0b" data-language-for-alternatives="zh-CN" data-language-to-translate-into="en" data-phrase-index="1">它基于分步护理模型，旨在提高对轻度，中度至重度抑郁症的认识和评估，并促进有效的治疗。</span></span></p>, tagList=[TagDto(tagId=228, tagName=抑郁症)], categoryList=[CategoryDto(categoryId=13, categoryName=精神心理科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=20, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=7360, appHits=518, showAppHits=0, pcHits=1077, showPcHits=6841, likes=3, shares=32, comments=39, approvalStatus=1, publishedTime=Mon Feb 15 22:55:30 CST 2021, publishedTimeString=2019-10-01, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Sat Feb 13 20:24:01 CST 2021, updatedBy=4754896, updatedName=fbzhang, updatedTime=Sat Jan 06 17:26:46 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.pdf)])
66.pdf
下载请点击：
评论区 (33)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2112915, encodeId=90b72112915cb, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96d08525371, createdName=ms5000000523501555, createdTime=Fri Feb 03 19:49:11 CST 2023, time=2023-02-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2099577, encodeId=c44220995e745, content=为了积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Thu Nov 10 11:05:18 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220671, encodeId=74ce12206e12b, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00562351440, createdName=122b0a30m85暂无昵称, createdTime=Wed May 18 14:55:04 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207378, encodeId=cfdc120e378e4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c212631393, createdName=283488816, createdTime=Wed Mar 30 23:03:24 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198799, encodeId=0aa31198e992d, content=值得参考, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048e6167235, createdName=ms1000001338777518, createdTime=Wed Mar 02 18:09:50 CST 2022, time=2022-03-02, status=1, ipAttribution=)]
    2023-02-03 ms5000000523501555 来自山西省

    积分

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2112915, encodeId=90b72112915cb, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96d08525371, createdName=ms5000000523501555, createdTime=Fri Feb 03 19:49:11 CST 2023, time=2023-02-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2099577, encodeId=c44220995e745, content=为了积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Thu Nov 10 11:05:18 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220671, encodeId=74ce12206e12b, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00562351440, createdName=122b0a30m85暂无昵称, createdTime=Wed May 18 14:55:04 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207378, encodeId=cfdc120e378e4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c212631393, createdName=283488816, createdTime=Wed Mar 30 23:03:24 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198799, encodeId=0aa31198e992d, content=值得参考, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048e6167235, createdName=ms1000001338777518, createdTime=Wed Mar 02 18:09:50 CST 2022, time=2022-03-02, status=1, ipAttribution=)]
    2022-11-10 ozzy

    为了积分

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2112915, encodeId=90b72112915cb, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96d08525371, createdName=ms5000000523501555, createdTime=Fri Feb 03 19:49:11 CST 2023, time=2023-02-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2099577, encodeId=c44220995e745, content=为了积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Thu Nov 10 11:05:18 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220671, encodeId=74ce12206e12b, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00562351440, createdName=122b0a30m85暂无昵称, createdTime=Wed May 18 14:55:04 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207378, encodeId=cfdc120e378e4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c212631393, createdName=283488816, createdTime=Wed Mar 30 23:03:24 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198799, encodeId=0aa31198e992d, content=值得参考, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048e6167235, createdName=ms1000001338777518, createdTime=Wed Mar 02 18:09:50 CST 2022, time=2022-03-02, status=1, ipAttribution=)]
    2022-05-18 122b0a30m85暂无昵称

    积分

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2112915, encodeId=90b72112915cb, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96d08525371, createdName=ms5000000523501555, createdTime=Fri Feb 03 19:49:11 CST 2023, time=2023-02-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2099577, encodeId=c44220995e745, content=为了积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Thu Nov 10 11:05:18 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220671, encodeId=74ce12206e12b, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00562351440, createdName=122b0a30m85暂无昵称, createdTime=Wed May 18 14:55:04 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207378, encodeId=cfdc120e378e4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c212631393, createdName=283488816, createdTime=Wed Mar 30 23:03:24 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198799, encodeId=0aa31198e992d, content=值得参考, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048e6167235, createdName=ms1000001338777518, createdTime=Wed Mar 02 18:09:50 CST 2022, time=2022-03-02, status=1, ipAttribution=)]
    2022-03-30 283488816

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2112915, encodeId=90b72112915cb, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96d08525371, createdName=ms5000000523501555, createdTime=Fri Feb 03 19:49:11 CST 2023, time=2023-02-03, status=1, ipAttribution=山西省), GetPortalCommentsPageByObjectIdResponse(id=2099577, encodeId=c44220995e745, content=为了积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/09716af288084795ba128059da55a818/c3137a18601c4c54bb7d71ac97630870.jpg, createdBy=e9985480565, createdName=ozzy, createdTime=Thu Nov 10 11:05:18 CST 2022, time=2022-11-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220671, encodeId=74ce12206e12b, content=积分, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=00562351440, createdName=122b0a30m85暂无昵称, createdTime=Wed May 18 14:55:04 CST 2022, time=2022-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207378, encodeId=cfdc120e378e4, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7c212631393, createdName=283488816, createdTime=Wed Mar 30 23:03:24 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1198799, encodeId=0aa31198e992d, content=值得参考, beContent=null, objectType=guider, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=048e6167235, createdName=ms1000001338777518, createdTime=Wed Mar 02 18:09:50 CST 2022, time=2022-03-02, status=1, ipAttribution=)]
    2022-03-02 ms1000001338777518

    值得参考

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2020 日本专家共识：抑郁症的药物治疗

国外精神科相关专家小组（统称） · 2020-01-28

2019 ISNPR实践指南：应用Omega-3脂肪酸治疗抑郁症

国外精神科相关专家小组（统称） · 2019-09-03

2019 临床实践指南：抑郁症与特定精神疾病共病的管理

国外精神科相关专家小组（统称） · 2019-01-30

阿戈美拉汀治疗抑郁症临床应用专家建议

中国精神科相关专家小组 · 2018-11-30

2018 AAP指南：基层医疗中青少年抑郁症的管理

美国儿科学会(AAP,American Academy of Pediatrics) · 2018-02-26

2017 佛罗里达最佳实践指南：成人抑郁症的药物治疗

国外精神科相关专家小组（统称） · 2017-06-10